Overall survival with [177Lu]Lu-PSMA-617 versus cabazitaxel in metastatic castration-resistant prostate cancer (TheraP): secondary outcomes of a randomised, open-label, phase 2 trial

- Hofman, Michael S., Emmett, Louise, Ng, Siobhan, Francis, Roslyn J., Gedye, Craig, Rutherford, Natalie K., Weickhardt, Andrew, Scott, Andrew M., Lee, Sze-Ting, Kwan, Edmond M., Azad, Arun A., Ramdave, Shakher, Sandhu, Shahneen, Redfern, AD, Macdonald, W, Guminski, A, Hsiao, E, Chua, W, Lin, P, Zhang, AY, Stockler, MR, Williams, SG, Martin, AJ, Iravani, Amir, Davis, ID, TheraP Trial Investigators and the Australian and New Zealand Urogenital and Prostate Cancer Trials Group,, Buteau, James P., Joshua, Anthony M., Goh, Jeffrey C., Pattison, David A., Tan, Thean Hsiang, Kirkwood, Ian D.

ProNGF Expression and Targeting in Glioblastoma Multiforme

- Marsland, Mark, Dowdell, Aimee, Jiang, Chen Chen, Hondermarck, Hubert, Faulkner, Sam, Jobling, Phillip, Rush, Robert A., Gedye, Craig, Lynam, James, Griffin, Cassandra P., Baker, Mark, Marsland, Joanne

Targeting XBP1 mRNA splicing sensitizes glioblastoma to chemotherapy

- Dowdell, Amiee, Marsland, Mark, Faulkner, Sam, Gedye, Craig, Lynam, James, Griffin, Cassandra P., Marsland, Joanne, Jiang, Chen Chen, Hondermarck, Hubert

The Membrane Protein Sortilin Is a Potential Biomarker and Target for Glioblastoma

- Marsland, Mark, Dowdell, Amiee, Faulkner, Sam, Gedye, Craig, Lynam, James, Griffin, Cassandra P., Marsland, Joanne, Jiang, Chen Chen, Hondermarck, Hubert

Find the path of least resistance: Adaptive therapy to delay treatment failure and improve outcomes

- Gedye, Craig, Navani, Vishal

Identifying the unmet supportive care needs of people affected by kidney cancer: a systematic review

- O’Dea, Amy, Gedye, Craig, Jago, Belinda, Paterson, Catherine

[Lu-177]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial

- Hofman, Michael S., Emmett, Louise, Francis, Roslyn J., Gedye, Craig, Rutherford, Natalie K., Weickhardt, Andrew, Scott, Andrew M., Lee, Sze-Ting, Kwan, Edmond M., Azad, Arun A., Ramdave, Shakher, Redfern, Andrew D., Sandhu, Shahneen, Macdonald, William, Guminski, Alex, Hsiao, Edward, Chua, Wei, Lin, Peter, Zhang, Alison Y., McJannett, Margaret M., Stockler, Martin R., Violet, John A., Williams, Scott G., Iravani, Amir, Martin, Andrew J., Davis, Ian D., Joshua, Anthony M., Goh, Jeffrey C., Pattison, David A., Tan, Thean Hsiang, Kirkwood, Ian D., Ng, Siobhan

A novel role for brain and acute leukemia cytoplasmic (BAALC) in human breast cancer metastasis

- Birgersson, Madeleine, Chi, Mengna, Miller, Chrissy, Brzozowski, Joshua S., Brown, Jeffrey, Schofield, Lachlan, Taylor, Olivia G., Pearsall, Elizabeth A., Hewitt, Jasmine, Gedye, Craig, Lincz, Lisa F., Skelding, Kathryn A.

Can hemp help? Low-THC cannabis and non-THC cannabinoids for the treatment of cancer

- Afrin, Farjana, Chi, Mengna, Eamens, Andrew L., Duchatel, Ryan J., Douglas, Alicia M., Schneider, Jennifer, Gedye, Craig, Woldu, Ameha S., Dun, Matthew D.

Driving innovation through collaboration: development of clinical annotation datasets for brain cancer biobanking

- Gedye, Craig, Sachchithananthan, Mythily, Nowak, Anna K., BCBA Consortium,, Leonard, Robyn, Jeffree, Rosalind L., Buckland, Michael E., Ziegler, David S., Graeber, Manuel B., Day, Bryan W., McDonald, Kerrie L., Lasocki, Arian

Infectious complications of biological and small molecule targeted immunomodulatory therapies

- Davis, Joshua S., Ferreira, David, Paige, Emma, Gedye, Craig, Boyle, Michael

Stem/progenitor cell marker expression in clear cell renal cell carcinoma: a potential relationship with the immune microenvironment to be explored

- Yoon, Ju-Yoon, Gedye, Craig, Paterson, Joshua, Ailles, Laurie

Patients' experiences and preferences for opt-in models and health professional involvement in biobanking consent: a cross-sectional survey of Australian cancer outpatients

- Fradgley, Elizabeth A., Chong, Shu Er, Cox, Martine E., Gedye, Craig, Paul, Christine L.

The precursor for nerve growth factor (ProNGF) in thyroid cancer lymph node metastases: correlation with primary tumour and pathological variables

- Rowe, Christopher W., Dill, Tony, Faulkner, Sam, Gedye, Craig, Paul, Jonathan W., Tolosa, Jorge M., Jones, Mark, King, Simon, Smith, Roger, Hondermarck, Hubert

The precursor for nerve growth factor (proNGF) is not a serum or biopsy-rinse biomarker for thyroid cancer diagnosis

- Rowe, Christopher W., Faulkner, Sam, Paul, Jonathan W., Tolosa, Jorge M., Gedye, Craig, Bendinelli, Cino, Wynne, Katie, McGrath, Shaun, Attia, John, Smith, Roger, Hondermarck, Hubert

Cell-Free DNA Blood Collection Tubes Are Appropriate for Clinical Proteomics: A Demonstration in Colorectal Cancer

- Almazi, Juhura G., Pockney, Peter, Gedye, Craig, Smith, Nathan D., Hondermarck, Hubert, Verrills, Nicole M., Dun, Matthew D.

Enlisting the willing: a study of healthcare professional-initiated and opt-in biobanking consent reveals improvement opportunities throughout the registration process

- Fradgley, Elizabeth A., Chong, Shu Er, Cox, Martine E., Paul, Christine L., Gedye, Craig

The diverse landscape of genitourinary cancer immunotherapy

- Gedye, Craig

An immune atlas of clear cell renal cell carcinoma

- Chevrier, Stephane, Levine, Jacob Harrison, van den Broek, Maries, Beisel, Christian, Stadler, Michael Beda, Gedye, Craig, Reis, Bernhard, Pe'er, Dana, Bodenmiller, Bernd, Zanotelli, Vito Riccardo Tomaso, Silina, Karina, Schulz, Daniel, Bacac, Marina, Ries, Carola Hermine, Ailles, Laurie, Jewett, Michael Alexander Spencer, Moch, Holger

Targeting the TSH receptor in thyroid cancer

- Rowe, Christopher W., Paul, Jonathan W., Gedye, Craig, Tolosa, Jorge M., Bendinelli, Cino, McGrath, Shaun, Smith, Roger